Cargando…

Expression of the Long Noncoding RNA GAS5 Correlates with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease

Background: Advanced liver fibrosis is the most important prognostic factor in nonalcoholic fatty liver disease (NAFLD). The long noncoding RNA (lncRNA), growth arrest-specific transcript 5 (GAS5), is associated with the inhibition of liver fibrogenesis, and its levels are decreased in cirrhotic liv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Man-Hoon, Lee, Jee Hyun, Kim, Gyeonghwa, Lee, Eunhye, Lee, Yu Rim, Jang, Se Young, Lee, Hye Won, Chun, Jae Min, Han, Young Seok, Yoon, Jun Sik, Kang, Min Kyu, Lee, Won Kee, Kweon, Young Oh, Tak, Won Young, Park, Soo Young, Park, Jung Gil, Hur, Keun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291058/ https://www.ncbi.nlm.nih.gov/pubmed/32413995 http://dx.doi.org/10.3390/genes11050545

Ejemplares similares

Diagnostic Efficacy of Serum Mac-2 Binding Protein Glycosylation Isomer and Other Markers for Liver Fibrosis in Non-Alcoholic Fatty Liver Diseases
por: Jang, Se Young, et al.
Publicado: (2021)

Circular Noncoding RNA hsa_circ_0003570 as a Prognostic Biomarker for Hepatocellular Carcinoma
por: Jang, Se Young, et al.
Publicado: (2022)

Plasma Long Noncoding RNA LeXis is a Potential Diagnostic Marker for Non-Alcoholic Steatohepatitis
por: Park, Jung Gil, et al.
Publicado: (2020)

Circular noncoding RNA hsa_circ_0005986 as a prognostic biomarker for hepatocellular carcinoma
por: Kim, Gyeonghwa, et al.
Publicado: (2021)

Association of Skeletal Muscle and Adipose Tissue Distribution with Histologic Severity of Non-Alcoholic Fatty Liver
por: Kang, Min-Kyu, et al.
Publicado: (2021)

Tissue Circular RNA_0004018 and 0003570 as Novel Prognostic Biomarkers for Hepatitis B-Related Hepatocellular Carcinoma
por: Kang, Min-Kyu, et al.
Publicado: (2023)

Long interspersed nuclear element-1 hypomethylation is associated with poor outcomes via the activation of ST18 in human hepatocellular carcinoma
por: Lee, Yu Rim, et al.
Publicado: (2021)

Clinical significance of lncRNA-ATB expression in human hepatocellular carcinoma
por: Jang, Se Young, et al.
Publicado: (2017)

Discrimination of Nonalcoholic Steatohepatitis Using Transient Elastography in Patients with Nonalcoholic Fatty Liver Disease
por: Lee, Hye Won, et al.
Publicado: (2016)

Association of Serum Adipocyte-Specific Fatty Acid Binding Protein with Fatty Liver Index as a Predictive Indicator of Nonalcoholic Fatty Liver Disease
por: Jeon, Won Seon, et al.
Publicado: (2013)

The Combination of Periostin Overexpression and Microvascular Invasion Is Related to a Poor Prognosis for Hepatocellular Carcinoma
por: Jang, Se Young, et al.
Publicado: (2016)

Metabolic Health Is More Important than Obesity in the Development of Nonalcoholic Fatty Liver Disease: A 4-Year Retrospective Study
por: Lee, Min-Kyung, et al.
Publicado: (2015)

Liver fibrosis is associated with risk for colorectal adenoma in patients with nonalcoholic fatty liver disease
por: Kim, Min Cheol, et al.
Publicado: (2019)

Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease
por: Kim, Young Seok, et al.
Publicado: (2013)

Increased Risk of Nonalcoholic Fatty Liver Disease in Individuals with High Weight Variability
por: Jung, Inha, et al.
Publicado: (2021)

Effects of branched-chain amino acids (BCAAs) on the progression of advanced liver disease: A Korean nationwide, multicenter, retrospective, observational, cohort study
por: Park, Jung Gil, et al.
Publicado: (2017)

Phospholipase D1 deficiency in mice causes nonalcoholic fatty liver disease via an autophagy defect
por: Hur, Jang Ho, et al.
Publicado: (2016)

Combined Effect of Nonalcoholic Fatty Liver Disease and Impaired Fasting Glucose on the Development of Type 2 Diabetes: A 4-year retrospective longitudinal study
por: Bae, Ji Cheol, et al.
Publicado: (2011)

Prognostic Impact of Myosteatosis on Mortality in Hospitalized Patients with COVID-19
por: Kang, Min-Kyu, et al.
Publicado: (2022)

Changes in Insulin Resistance Index and the Risk of Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease without Diabetes: Kangbuk Samsung Health Study
por: Koo, Dae-Jeong, et al.
Publicado: (2021)

Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
por: Lee, Jae Seung, et al.
Publicado: (2021)

Thrombocytopenia represents a risk for deterioration of liver function after radiofrequency ablation in patients with hepatocellular carcinoma
por: Lee, Hyun Seok, et al.
Publicado: (2012)

Effects of Branched-Chain Amino Acid (BCAA) Supplementation on the Progression of Advanced Liver Disease: A Korean Nationwide, Multicenter, Prospective, Observational, Cohort Study
por: Park, Jung Gil, et al.
Publicado: (2020)

Clinical outcomes of coronavirus disease 2019 in patients with pre-existing liver diseases: A multicenter study in South Korea
por: Lee, Yu Rim, et al.
Publicado: (2020)

Tumor Necrosis Factor-α as a Predictor for the Development of Nonalcoholic Fatty Liver Disease: A 4-Year Follow-Up Study
por: Seo, Yun Yong, et al.
Publicado: (2013)

Visceral-to-Subcutaneous Abdominal Fat Ratio Is Associated with Nonalcoholic Fatty Liver Disease and Liver Fibrosis
por: Jung, Chan-Hee, et al.
Publicado: (2020)

Development and Validation of a Difficulty Scoring System for Laparoscopic Liver Resection to Treat Hepatolithiasis
por: Jo, Yeongsoo, et al.
Publicado: (2022)

Autonomic Imbalance Increases the Risk for Non-alcoholic Fatty Liver Disease
por: Jung, Inha, et al.
Publicado: (2021)

Treatment Outcomes and Prognostic Factors of Acute Variceal Bleeding in Patients with Hepatocellular Carcinoma
por: Lee, Yu Rim, et al.
Publicado: (2020)

Increased risk for development of coronary artery calcification in subjects with non-alcoholic fatty liver disease and systemic inflammation
por: Kim, Jihyun, et al.
Publicado: (2017)

Recent research trends and updates on nonalcoholic fatty liver disease
por: Yoo, Jeong-Ju, et al.
Publicado: (2019)

Associations of Serum Uric Acid Level With Liver Enzymes, Nonalcoholic Fatty Liver Disease, and Liver Fibrosis in Korean Men and Women: A Cross-Sectional Study Using Nationally Representative Data
por: Lee, Jun Myong, et al.
Publicado: (2023)

Unraveling the Antioxidant Capacity of Spatholobi caulis in Nonalcoholic Fatty Liver Disease: A Multiscale Network Approach Integrated with Experimental Validation
por: Bae, Su-Jin, et al.
Publicado: (2023)

Percutaneous portal vein embolization for intractable hepatic biloma after radiofrequency ablation
por: Cha, Jung Guen, et al.
Publicado: (2020)

Higher association of coronary artery calcification with non-alcoholic fatty liver disease than with abdominal obesity in middle-aged Korean men: the Kangbuk Samsung Health Study
por: Lee, Min-Kyung, et al.
Publicado: (2015)

Correlation between the small dense LDL level and nonalcoholic fatty liver disease: Possibility of a new biomarker
por: Hwang, Ha Won, et al.
Publicado: (2020)

Factors Associated or Related to with Pathological Severity of Nonalcoholic Fatty Liver Disease
por: Park, Kyung Sik, et al.
Publicado: (2004)

Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease
por: Kim, Yuna, et al.
Publicado: (2022)

Bifidobacterium-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axis
por: Yoon, Sang Jun, et al.
Publicado: (2023)

A case of hemocholecyst associated with hemobilia following radiofrequency ablation therapy for hepatocellular carcinoma
por: Shin, Keun Young, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_eql0bn2qkp49i74eg501j4c1lt